Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs NYT✓SelectedUSD · NYTGSK vs NYT performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs NYT

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+52.7%
NYT return
+59.2%
Excess return
-6.4%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioNYTExcessAlpha
1D-0.1%-0.6%+0.5%-0.1%
7D-5.3%-5.8%+0.4%-5.1%
30D-3.7%-0.3%-3.3%-3.6%
3M-7.3%+5.5%-12.7%-7.3%
6M-4.2%-7.1%+2.8%-4.2%
YTD+0.9%0.0%+0.8%+1.3%
1Y+7.3%+9.3%-2.0%+7.9%
3Y+52.7%+56.4%-3.7%+46.7%
All+52.7%+59.2%-6.4%+46.7%

Cumulative growth

Daily Returns

Daily percentage return beside NYT.

Daily Out/Under-Performance

Portfolio return minus NYT return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × NYT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded NYT wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling